Liraglutide (Saxenda) NICE Technology Appraisal TA664 recommends liraglutide as an option for managing overweight and obesity in adults with a BMI of 35 kg/m or more (or 3034.9 kg/m in certain circumstances) alongside at least one weight-related comorbidity, within a specialist weight management service
Billing one unit for a 200 mg dose results in underpayment of approximately $7-11 per claim
Elevated cAMP leads to activation of protein kinase A, which regulates key enzymes involved in triglyceride breakdown
ACS Nano 12:32953310 Ju X, Fan D, Kong L, Yang Q, Zhu Y, Zhang S, Su G, Li Y (2021) Antimicrobial peptide Brevinin-1RL1 from frog skin secretion induces apoptosis and necrosis of tumor cells
This is normal and usually heals quickly